Our article earned a top 10 ranking this year… …
[ad_1] Our article earned a top 10 ranking this year… https://t.co/3eBjWfXmEv [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
Month: December 2021
RT @ThomasCiullaMD: Recently published, “Genes and Gene Therapy in Inherited Ret…
[ad_1] RT @ThomasCiullaMD: Recently published, “Genes and Gene Therapy in Inherited Retinal Disease”. #eye #ophthalmology #retina #gene #genether… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
Honored to be recognized as a global expert in #maculardegeneration , a leading …
[ad_1]
Honored to be recognized as a global expert in #maculardegeneration , a leading cause of irreversible vision loss: https://t.co/xLn1Vsjj5a
This recognition is based on scientific publications over the last 10 years, an objective process…
#AMD #retina #ASRS #clinicalresearch https://t.co/l9bnt4FRuj
[ad_2]
Source by Thomas Ciulla, MD, MBA
Just published: Long-Term Outcomes of Anti-VEGF Therapy. Treatment burden is a …
[ad_1] Just published: Long-Term Outcomes of Anti-VEGF Therapy. Treatment burden is a barrier to real world #outcomes in #AMD, #diabetic & vein occlusion macular edema. Longer acting and more effective treatments are needed… #eye #retina @RetinaToday https://t.co/GuqOGPpmFM [ad_2] Source by Thomas Ciulla, MD, MBA Return …
RT @OTEurope: XIPERE, the first therapy utilising the suprachoroidal space, demo…
[ad_1] RT @OTEurope: XIPERE, the first therapy utilising the suprachoroidal space, demonstrates rapid efficacy, durable benefit and favourable saf… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ModernRetina: The first retinal gene therapy, voretigene neparvovec-rzyl (Lu…
[ad_1]
RT @ModernRetina: The first retinal gene therapy, voretigene neparvovec-rzyl (Luxturna, Spark Therapeutics), was approved by the FDA in 20…
[ad_2]
Source by Thomas Ciulla, MD, MBA
Pleased to co-edit the 2nd of 2 #genetherapy issues of International Ophthalmolo…
[ad_1] Pleased to co-edit the 2nd of 2 #genetherapy issues of International Ophthalmology Clinics: “DNA- and RNA-based Gene Therapies in Ophthalmology: Inherited and Noninherited Retinal Disorders” #eye #ophthalmology #retina #IRD #gene https://t.co/4N9toRLDTO [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
Recently published, “Genes and Gene Therapy in Inherited Retinal Disease”. #eye …
[ad_1] Recently published, “Genes and Gene Therapy in Inherited Retinal Disease”. #eye #ophthalmology #retina #gene #genetherapy #Luxturna #IRD #clinicalresearch #clinicaltrials #drugdevelopment #biotech https://t.co/u17zTf9Oox [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ThomasCiullaMD: Looking forward to presenting on #suprachoroidal delivery at…
[ad_1]
RT @ThomasCiullaMD: Looking forward to presenting on #suprachoroidal delivery at the Ophthalmology Innovation Source Drug Delivery Innovati…
[ad_2]
Source by Thomas Ciulla, MD, MBA
RT @BauschSurgical: B+L and Clearside Biomedical announce the FDA approval of XI…
[ad_1] RT @BauschSurgical: B+L and Clearside Biomedical announce the FDA approval of XIPERE™ which utilizes the suprachoroidal space to treat pati… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.